JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for Mereo BioPharma Group plc American Depositary Shares (MREO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
Mereo BioPharma Group plc American Depositary Shares
Symbol
MREO
Shares outstanding
155,659,664 shares
Disclosed Ownership
17,122,563 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 12:09:16 UTC
Date of event
31 Dec 2024
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 11% 17,122,563 0 17,122,563 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 10% 15,589,805 0 15,589,805 Kristin Mariani Head of North America Compliance, CCO